Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine dose-ranging trial to prevent fentanyl-induced cough during anesthesia induction
IRCT20200825048515N55Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of ketamine in cough (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Cough intensity, Blood pressure and 2 more. Started Jul 2022; status: completed.
02
Drugs
ketamine
03
Conditions
cough
Beyond the preview
Go deeper on IRCT20200825048515N55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N55.